Mar 31, 2016
Notes to Accounts:
1. Segment Reporting:
Based on the guiding principles given in Accounting Standard on Segment Reporting (AS -17) issued by the Institute of Chartered Accountants of India the company''s primary business segment is Formulations. During the period your company has achieved a turnover of Rs 3285.54 lacs for Formulations & Feed Supplement.
2 Investment in Total Health Kare International Private Limited subsidiary of Celestial Biolabs Ltd of
Rs. 30.10 Lakhs
4) Paise have been rounded off to the nearest Rupee.
5) On applicability of revised Schedule II from current year, the Company has reclassified previous year figures to conform to this year''s classification. The adoption of revised Schedule II does not impact recognition and measurement principles followed for preparation of the financial statements. However, it significantly impacts presentation and disclosures made in the financial statements, particularly presentation of Balance Sheet.
6).Balance in respect of creditors, Various Advances, Sundry Debtors are subject to confirmation from the respective parties.
7).As the company has not in the possession of information regarding dues to the Micro, Small and Medium Enterprises, the same has not been furnished herewith.
8). Additional Information required under Part II of Schedule V to the Companies Act 2013.
a) Capacities and Production
Product Unit Installed capacity / Actual Production Not Applicable
Licensed Capacity Not Applicable
Mar 31, 2015
1. Segment Reporting:
Based on the guiding principles given in Accounting Standard on Segment
Reporting (AS -17) issued by the Institute of Chartered Accountants of
India the company's primary business segment is formulations. During
the period your company has achieved a turnover of Rs 2745.07 lacs for
formulations.
2. Contingent Liabilities : Nil
3. Paise have been rounded off to the nearest Rupee.
4. On applicability of revised Schedule VI from current year, the
Company has reclassified previous year figures to conform to this
year's classification. The adoption of revised Schedule VI does not
impact recognition and measurement principles followed for preparation
of the financial statements. However, it significantly impacts
presentation and disclosures made in the financial statements,
particularly presentation of Balance Sheet.
5. Balance in respect of creditors, Various Advances, Sundry Debtors
are subject to confirmation from the respective parties.
6. As the company has not in the possession of information regarding
dues to the Micro, Small and Medium Enterprises, the same has not been
furnished herewith.
Mar 31, 2014
1. Segment Reporting:
Based on the guiding principles given in Accounting Standard on Segment
Reporting (AS -17) issued by the Institute of Chartered Accountants of
India the company''s primary business segment is formulations. During
the period your company has achieved a turnover of Rs 2350.34 lacs for
formulations.
2. Related Party disclosures:
SL No Name of Related Party Name of the Transaction Amount
1 Dr. A.N. Singh Remuneration 12.00
2 Padma Singh Sitting Fee 0.10
3 Amit Kumar Singh remuneration 6.00
3. Auditors'' Remuneration:
2013-2014 2012-2013
Rs. Rs.
Audit Fee 3,00,000 3,00,000
4. Treatment of Contingent Liabilities : Liabilities, Which may or may
not arise and not crystallized as at the year - end, have been taken as
contingent liability. Claims against the company not knowledge as debt
in respect of Sales tax and Income Tax Rs. 1.25 crore and Rs.299.06
Lacs respectively
5. Paise have been rounded off to the nearest Rupee.
6. On applicability of revised Schedule VI from current year, the
Company has reclassified previous year figures to conform to this
year''s classification. The adoption of revised Schedule VI does not
impact recognition and measurement principles followed for preparation
of the financial statements. However, it significantly impacts
presentation and disclosures made in the financial statements,
particularly presentation of Balance Sheet.
7.Balance in respect of creditors, Various Advances, Sundry Debtors
are subject to confirmation from the respective parties.
8.As the company has not in the possession of information regarding
dues to the Micro, Small and Medium Enterprises, the same has not been
furnished herewith.
9). Additional Information required under Part II of Schedule VI to
the Companies Act 1956. a) Capacities and Production Product Unit
Installed capacity / Actual Production Not Applicable Licensed Capacity
Not Applicable
10. TECHNOLOGY ABSORPTION: A. Research & Development (R & D)
1 Specific area in which R & D carried out by the company
Isolating the compound from Herbs to identify the active ingredient for
diabetes, Obesity & HIV virus.
2 Benefits derived as a result of the above R & D
Lead have been identified and the further process is in progress.
3 Future plan of action
We will continue to work on clinical trial of Bio drug Molecules
already in pipe line and isolating the compounds for our target
decease.
4 Expenditure on R & D: (Rs. In Lakhs)
2013-14 2012-13
a. Capital 250.00 350.41
b. Recurring 105.64 118.68
c. Total 355.64 469.09
d. Total R & D expenditure as a 15.13% 22.17%
percentage of total turnover
Procedure and Instructions for E-Voting are as follows:
i) Open your web browser during the voting period and navigate to
''https://evoting.karvy.com''
ii) Enter the login credentials (i.e., user-id & password) mentioned on
the Postal Ballot Form. Your folio/DP Client ID will be your User-ID.
User-ID
For Members holding shares in Demat Form:-
a) For NSDL :- 8 Character DP ID followed by 8 Digits Client ID
b) For CDSL :- 16 digits beneficiary ID
For Members holding shares in Physical Form:-
- Event no. followed by Folio Number registered with the company
Password
Your Unique password is printed on the Postal Ballot Form / via email
forwarded through the electronic notice
Captcha
Enter the Verification code i.e., please enter the alphabets and
numbers in the exact way as they are displayed for security
reasons.
iii) Please contact our toll free No. 1-800-34-54-001 for any further
clarifications.
iv) Members can cast their vote online from Monday 10th November, 2014
@ 10:00 AM to Wednesday 12th November, 2014 @ 6:00 PM
v) After entering these details appropriately, click on "LOGIN".
vi) Members holding shares in Demat/Physical form will now reach
Password Change menu wherein they are required to mandatorily change
their login password in the new password field. The new password has to
be minimum eight characters consisting of atleast one upper case
(A-Z).one lower case (a-z), one numeric value (0-9) and a special
character. Kindly note that this password can be used by the Demat
holders for voting for resolution of any other Company on which they
are eligible to vote, provided that Company opts for e-voting through
Karvy Computershare Private Limited e-Voting platform. System will
prompt you to change your password and update any contact details like
mobile #, email ID etc on 1st login. You may also enter the Secret
Question and answer of your choice to retrieve your password in case
you forget it. It is strongly recommended not to share your password
with any other person and take utmost care to keep your password
confidential.
vii) You need to login again with the new credentials.
viii) On successful login, system will prompt to select the ''Event''
i.e., ''Company Name''.
ix) If you are holding shares in Demat form and had logged on to
"https://evoting.karvy.com" and casted your vote earlier for any
company, then your existing login id and password are to be used.
x) On the voting page, you will see Resolution Description and against
the same the option ''FOR/AGAINST/ABSTAIN'' for voting Enter the number
of shares (which represents number of votes) under
''FOR/AGAINST/ABSTAIN'' or alternatively you may partially enter any
number in ''FOR and partially in ''AGAINST'', but the total number in
''FOR/AGAINST'' taken together should not exceed your total shareholding.
If the shareholder do not wants to cast, select''ABSTAIN''
xi) After selecting the resolution you have decided to vote on, click
on "SUBMIT''.A confirmation box will be displayed .If you wish to
confirm your vote, click on "OK", else to change your vote, click on "
CANCEL "and accordingly modify your vote.
xii) Once you ''CONFIRM'' your vote on the resolution, you will not be
allowed to modify your vote.
xiii) Corporate/Institutional Members (corporate /Fls/Flls/Trust/Mutual
Funds/Banks, etc) are required to send scan (PDF format) of the
relevant Board resolution to the Scrutinizer through e-mail to
[email protected] with copy to [email protected] file scanned
image of the Board Resolution should be in the naming format "Corporate
Name_ Event no.". Please follow all steps from Sl. No. (i) to Sl. No.
(xiii) above, to cast vote.
Mar 31, 2013
1 Related Party Disclosures
The Company had no transactions with related parties as defined in
Accounting Standard - 18 issued by the Institute of Chartered
Accountants of India.
2 Treatment of Contingent Liabilities: Liabilities, which may or may
not arise and not crystallized as at the year- end, have been taken as
contingent liability. Claims against the Company not acknow- ledged as
Debt in respect of Sales Tax and Income Tax Rs.390.48 Lacs and Rs
299.06 Lacs respectively.
3 CIF Value of Imports NIL NIL
4 Expenditure in Foreign Currency NIL Nil
(on account of Travelling & Professional and Consultancy)
5 Earnings in Foreign Exchange - FOB value of Exports NIL NIL
6 The company operates predominantly only in one Business Segment viz:
Herbal, Allopathic etc Products. The sales of the company is mostly in
India and there are no reportable geographical segments.
7 The Balances of Loans & Advances, Sundry Debtors and Sundry
Creditors are subject to confirmation.
8 The Revised Schedule VI has become effective from 1 April 2012 for
the preparation of financial statements. Previous year figures have
been regrouped / reclassified wherever necessary to correspond with the
current year''s classification / disclosure.
9. Segment Reporting:
Based on the guiding principles given in Accounting Standard on Segment
Reporting (AS -17) issued by the Institute of Chartered Accountants of
India the company''s primary business segment is formulations. During
the period your company has achieved a turnover of Rs 2115.54 lakh for
formulations.
10) Paise have been rounded off to the nearest Rupee.
11) On applicability of revised Schedule VI from current year, the
Company has reclassified previous year figures to conform to this
year''s classification. The adoption of revised Schedule VI does not
impact recognition and measurement principles followed for preparation
of the financial statements. However, it significantly impacts
presentation and disclosures made in the financial statements,
particularly presentation of Balance Sheet.
12). Balance in respect of creditors, Various Advances, Sundry Debtors
are subject to confirmation from the respective parties.
13). As the company has not in the possession of information regarding
dues to the Micro, Small and Medium Enterprises, the same has not been
furnished herewith.
Mar 31, 2012
1. Segment Reporting:
Based on the guiding principles given in Accounting Standard on Segment
Reporting (AS -17) issued by the Institute of Chartered Accountants of
India the company's primary business segment is formulations. During
the period your company has achieved a turnover of Rs 1324.35 lakh for
formulations and Rs 734.53 lakh for Bio IT.
2.Managerial Remuneration under Section 198 of the Companies Act, 1956
paid or payable to the Directors:
3) Paise have been rounded off to the nearest Rupee.
4) On applicability of revised Schedule VI from current year, the
Company has reclassified previous year figures to conform to this
year's classification. The adoption of revised Schedule VI does not
impact recognition and measurement principles followed for preparation
of the financial statements. However, it significantly impacts
presentation and disclosures made in the financial statements,
particularly presentation of Balance Sheet.
5).Balance in respect of creditors, Various Advances, Sundry Debtors
are subject to confirmation from the respective parties.
6).As the company has not in the possession of information regarding
dues to the Micro, Small and Medium Enterprises, the same has not been
furnished herewith.
Mar 31, 2011
1.1 Contingent Liabilities not provided à Nil
1.2 Segment Reporting:
Based on the guiding principles given in Accounting Standard on Segment
Reporting (AS -17) issued by the Institute of Chartered Accountants of
India, the company's primary business segment is formulations. During
the period your company has achieved a turn over of Rs.1760.31 lakh for
formulations and Rs.762.01 lakh for Bio/IT.
1.3 Deferred Tax
The deferred tax asset as at 31st March 2011 is . 16, 01,592.00
Mar 31, 2010
1.1 Contingent Liabilities not provided -Nil
1.2 Segment Reporting:
Based on the guiding principles given in Accounting Standard on Segment
Reporting (AS -17) issued by the Institute of Chartered Accountants of
India, the companys primary business segment is formulations. During
the period your company has achieved a turn over of Rs.1447.23 lakh for
formulations and Rs.705.99 lakh for Bio-IT.
1.3 Deferred fax
The deferred tax asset as at 31st March 2010 is Rs. 6,87,866.00
1.4 Additional information required under Part II of Schedule VI to the
Companies Act, 1956
1. Capacities and & Production
Product Unit Installed capacity/Actual production Not Applicable
Licensed Capacity Not Applicable
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article